AvePoint, Inc.
AvePoint, Inc. (AVPT) Financial Performance & Income Statement Overview
Analyze AvePoint, Inc. (AVPT) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
AvePoint, Inc. (AVPT) Income Statement & Financial Overview
Analyze AvePoint, Inc.’s AVPT earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $93.06M | $89.18M | $88.80M | $77.96M |
| Cost of Revenue | $23.90M | $21.92M | $21.22M | $18.94M |
| Gross Profit | $69.17M | $67.26M | $67.58M | $59.02M |
| Gross Profit Ratio | $0.74 | $0.75 | $0.76 | $0.76 |
| R&D Expenses | $12.69M | $12.87M | $12.84M | $12.50M |
| SG&A Expenses | $53.19M | $49.54M | $47.09M | $48.65M |
| Operating Expenses | $65.88M | $62.41M | $59.93M | $61.16M |
| Total Costs & Expenses | $89.78M | $84.33M | $81.15M | $80.10M |
| Interest Income | $0.00 | $50000.00 | $45000.00 | $37000.00 |
| Interest Expense | $299000.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $1.51M | $1.36M | $1.40M | $1.33M |
| EBITDA | $4.80M | $6.21M | $9.05M | -$810000.00 |
| EBITDA Ratio | $0.05 | $0.07 | $0.10 | -$0.01 |
| Operating Income | $3.29M | $4.85M | $7.65M | -$2.14M |
| Operating Income Ratio | $0.04 | $0.05 | $0.09 | -$0.03 |
| Other Income/Expenses (Net) | $1.59M | -$23.46M | -$4.54M | -$6.97M |
| Income Before Tax | $4.87M | -$18.61M | $3.11M | -$9.11M |
| Income Before Tax Ratio | $0.05 | -$0.21 | $0.04 | -$0.12 |
| Income Tax Expense | $1.31M | -$1.43M | $183000.00 | $3.83M |
| Net Income | $3.44M | -$17.18M | $2.62M | -$12.81M |
| Net Income Ratio | $0.04 | -$0.19 | $0.03 | -$0.16 |
| EPS | $0.02 | -$0.09 | $0.01 | -$0.07 |
| Diluted EPS | $0.02 | -$0.09 | $0.01 | -$0.07 |
| Weighted Avg Shares Outstanding | $197.92M | $183.72M | $183.95M | $182.80M |
| Weighted Avg Shares Outstanding (Diluted) | $224.57M | $186.60M | $203.86M | $182.80M |
Financial performance has remained strong, with revenue growing from $77.96M in Q2 2024 to $93.06M in Q1 2025. Gross profit continued to perform well, with margins at 74% in the latest quarter. Operating income reached $3.29M in Q1 2025, holding a steady 4% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $4.80M. Net income rose to $3.44M, keeping EPS at $0.02. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan